• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

The conhIT AppCircus goes in search of the best health app

, 26 August 2020/in E-News /by 3wmedia

At conhIT – Connecting Healthcare IT, Europe’s leading event for the Health IT industry which takes place from 19 to 21 April in Berlin – a competition will be presenting an award for the best health app once again.
This event, part of the internationally recognized AppCircus series, will be taking place for the second time, and is regarded as the world’s biggest competition for mHealth apps. Taking part gives companies and mHealth app developers an opportunity to present their products to an outstanding audience and to increase awareness of their companies in the Health IT sector. At conhIT 2016 more than 7,500 visitors and some 400 exhibitors are expected to attend.
The competition will be looking for an app that assists the daily work of medical professionals, nurses and patients and can be used in Europe in hospitals, rehab centres, care homes and general patient care.
The award ceremony will take place on 20 April 2016 in the mobile health zone at conhIT. This section of the exhibition focuses on innovations and trends in mobile health applications.   
The winner of the conhIT AppCircus competition will be nominated for the Mobile Premier Awards, the world’s biggest app exhibition at the Mobile World Congress in Barcelona.
www.conhit.com

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:41The conhIT AppCircus goes in search of the best health app

Optimal care for older cancer patients should target relevant HRQOL domains

, 26 August 2020/in E-News /by 3wmedia

In a paper recently published, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.

Dr. Andrew Bottomley, Head of the EORTC Quality of Life Department and senior  investigator of this study says,

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:50Optimal care for older cancer patients should target relevant HRQOL domains

Hybrid molecule delivers a blow to malignant cells

, 26 August 2020/in E-News /by 3wmedia

A new hybrid molecule developed in the lab at the NYU Tandon School of Engineering shows promise for treating breast cancer by serving as a

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:36Hybrid molecule delivers a blow to malignant cells

Breast screening programme effective in preventing some invasive cancers

, 26 August 2020/in E-News /by 3wmedia

Ductal carcinoma in situ (DCIS) is described as a very early form of breast cancer, where cancer cells are present in milk ducts, but have not yet invaded the surrounding breast tissue. Around 4,800 people are diagnosed with DCIS in the UK each year and the main form of treatment is surgery followed by radiotherapy.
Ongoing public debate about the harm caused by mammography screening through over-diagnosis has led to controversy over the value of screening for and treatment of DCIS. A major question has been the extent to which diagnosis and treatment of DCIS may prevent the occurrence of invasive breast cancer in the future.
The researchers analysed data on 5,243,658 women aged 50-64 who were screened over a four year period across 84 screening units in the UK

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:44Breast screening programme effective in preventing some invasive cancers

New syringe design not particularly effective at curbing spread of Hepatitis C virus

, 26 August 2020/in E-News /by 3wmedia

Researchers examined the internal design of syringes to see if variations affected the transmission of hepatitis C virus.
As many as 21 million people worldwide inject drugs, putting them at heightened risk for infection from blood-borne pathogens such as the hepatitis C virus (HCV), especially if syringes are shared.

A newer type of syringe designed to reduce HCV transmission by decreasing the so-called dead space

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:52New syringe design not particularly effective at curbing spread of Hepatitis C virus

Custom Android MyHealth mobile app

, 26 August 2020/in E-News /by 3wmedia

Stanford Health Care recently released a new app that allows patients using Android smartphones to easily access their own medical information anywhere in the world. The Android version and the iOS 8 MyHealth mobile app are both designed to put a patient’s health information right at their fingertips, making it quick and simple for them to manage their care, including reviewing test results, paying medical bills, managing prescriptions, scheduling appointments, and conducting video visits with Stanford physicians.
‘At Stanford Health Care we are continuing to develop a suite of mobile offerings and innovations that empower our patients, making it easy and convenient for them to access the information and tools they need to manage their health,’ said Pravene Nath, MD, Chief Information Officer, Stanford Health Care. ‘By developing and incorporating new digital technology and leveraging available health data, we are providing increased, flexible opportunities for patients to engage with clinicians and better manage their overall care.’
Over 200,000 people are now messaging their physicians, scheduling appointments, and reviewing their medical records through Stanford Health Care’s MyHealth. The in-house developed apps leverage Stanford Health Care’s digital platform, which with its electronic health record integration provides a seamless experience for the user to get all the important health information they need. Additionally, the apps allow patients to communicate directly with their care team through a confidential and secure messaging system, and make quick, easy, and secure online payments.
This latest version also includes new features such as:
TouchID for faster and more secure entry; and In app and Apple Watch alerts when new lab results and messages from the patient’s care team are received.

Stanford Health Care http://tinyurl.com/zmfwdv8

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:05Custom Android MyHealth mobile app

Medical diagnosis: brain palpation soon possible?

, 26 August 2020/in E-News /by 3wmedia

If there is a technical exploration of the human body that the physician practice in any medical examination to diagnose or prescribe additional tests, it is palpation. The brain, however, has the distinction of being not possible to feel without a very invasive procedure (opening of the skull) reserved for rare cases. Drawing on seismology, researchers from Inserm led by Stefan Catheline (Inserm Unit 1032 ‘Applications of Ultrasound therapy’) have developed a non-invasive method of imaging of the brain by MRI which gives the same indications as physical palpation. A term may be used for early diagnosis of brain tumours or of Alzheimer’s disease.
The Inserm researchers have managed, via MRI to detect natural brain shear waves using computational techniques borrowed from seismologists and known as ‘noise correlation.’ They were able to draw of brain elasticity image.
‘If this method can be developed in the clinic, it would be both a comfort for the patient and the doctor because today vibrating the brain is painful enough. Of course, this method will be complementary to the existing ones and the future is a multimodal medical diagnosis, ‘says Stefan Catheline, Senior Research Director Inserm author of this work.
‘Alzheimer’s disease, epilepsy, multiple sclerosis, hydrocephalus involve changes in the hardness of brain tissue. This new technique could detect those changes and be used to prevent brain biopsies.’
This method of brain palpation could have other application areas such as the analysis of the development of neurodegenerative processes, the impact of a traumatic injury or tumour, or the response to treatment.

INSERM http://tinyurl.com/zhyjj9x

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:13Medical diagnosis: brain palpation soon possible?

New system to measure dry blood samples used in infant HIV screening, testing for metabolic disorders

, 26 August 2020/in E-News /by 3wmedia

Researchers from The University of Texas at Arlington have demonstrated that electrical conductivity can be an effective means to precisely measure the amount of blood present in dry blood spot analysis, providing a new alternative to the current preferred approach of measuring sodium levels.
Dry blood spots are a pinprick of blood blotted on filter paper and allowed to air dry, which is then sent to a laboratory for analysis. Simple and inexpensive, dry blood spot analysis is routinely used to screen newborns for metabolic disorders and has also proven effective in diagnosing infant HIV infection, especially in developing countries where health budgets are limited.
‘Our new method, which involves using an electrode probe to measure electrical conductivity, has proven accurate to within one percent,’ said Purnendu Dasgupta, Hamish Small Chair in Ion Analysis and James Garrett Professor in UTA’s Department of Chemistry and Biochemistry. ‘It also has the considerable advantage of using up none of the sample where the currently preferred approach uses around half the sample.’

Dasgupta and his co-researchers used 12 volunteers aged 20 to 66, taking pinpricks of blood and letting the dry blood spot samples dry. They then took a 3 millimeter punch out of each dry blood spot, dissolved the punch in methanol and water mixtures and used a dip-type small diameter ring-disk electrode to measure the conductance of the samples, determining the minimum immersion depth that proved accurate in measuring the amount of blood to within one percent.
‘As analytical instrumentation has improved, dry blood spot analysis is becoming increasingly popular for clinical trials to monitor the effects of therapeutic drugs and for large-scale epidemiology and genetic studies, where it is vital to know the exact amount of blood in the sample,’ Dasgupta said. ‘Our new dip probe method offers clear advantages, but it does have the same problem as measuring sodium in that it does not function if the subject has abnormal electrolyte levels, which happens in some diseases.’

www.uta.edu/news/releases/2016/07/Dasgupta%20Blood%20Spots.php

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:21New system to measure dry blood samples used in infant HIV screening, testing for metabolic disorders

Study yields new knowledge about materials for ultrasound and other applications

, 26 August 2020/in E-News /by 3wmedia

Piezoelectric materials turn mechanical stress into electrical energy, and vice versa. In 1997, researchers developed piezoelectric materials that were 10 times better at coupling electrical and mechanical responses than prior state-of-the-art materials. But even scientists did not understand why the newer materials were so responsive.
Now, scientists at the Department of Energy’s Oak Ridge National Laboratory and their research partners have used neutron scattering to discover the key to piezoelectric excellence in the newer materials, which are called relaxor-based ferroelectrics. (A ferroelectric material has electrical polarization that is reversed by application of an electric field.) Their findings may provide knowledge needed to accelerate the design of functional materials for diverse applications.
Relaxor-based oxide ferroelectrics have revolutionized piezoelectric devices. In medical ultrasound, for example, the mechanical pressure of sound waves generates images of a person’s interior. Compared with the performance of traditional materials, the stronger response of relaxor-based ferroelectrics yields a more detailed electrical signal that produces better images. Instead of having somewhat blurry guidance from 2D images to diagnose a cause of pain, assess prenatal condition, guide a biopsy or assess damage after a heart attack, doctors now rely on finely detailed 3D imagery. These modern materials also made it possible to focus ultrasound waves for non-invasive medical treatments of conditions such as tumours or gallstones. This technology passes individual beams harmlessly through tissue; the beams converge on a target where their effects are concentrated, like light passing through a magnifying glass to ignite paper.
‘We figured out at an atomic level why certain materials are so great at mechanically responding to an electric field by changing shape or size,’ said lead author Michael Manley of ORNL. ‘The finding provides a basis for high-performance actuators and sensors.’ Compared to traditional polycrystalline materials, the newer piezoelectric crystals generate a greater mechanical force in response to an applied electric field.

Oak Ridge National Laboratory http://tinyurl.com/j57s466

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:08Study yields new knowledge about materials for ultrasound and other applications

How to identify high risk heart disease patients

, 26 August 2020/in E-News /by 3wmedia

A new study shows that magnetic resonance imaging (MRI) scans are the safest and most effective way to identify high risk patients with cardiac chest pain.
The research, funded by the British Heart Foundation (BHF), showed that cardiac MRI was better overall at predicting serious events, such as death or heart attack, following chest pain suspected to be angina.
The researchers from the University of Leeds carried out a five-year follow-up study in 750 people, to find out the best way of separating patients based on whether they were at high- or low-risk of serious heart events.
They compared MRI scans, a non-invasive test which does not use potentially dangerous radiation, with SPECT, a procedure which uses ionizing radiation and is commonly used in the diagnosis of coronary heart disease.
Coronary heart disease (CHD), the world’s biggest killer, is responsible for nearly 70,000 deaths in the UK each year, an average of 190 people each day, or one death around every eight minutes.
Most deaths from CHD are caused by a heart attack. CHD occurs when the vital arteries which serve the heart are narrowed or blocked by a build-up of fatty tissues. This can cause chest pain, or angina, which can lead to a heart attack if left untreated.
When a person has suspected angina, they are most likely to be tested with either an X-ray angiogram, an invasive procedure which uses a type of radio-opaque dye to image the inside of the arteries, or SPECT, a non-invasive procedure which also involves ionizing radiation. Ionizing radiation is damaging to living cells.
In contrast, MRI scans use strong magnetic fields and radio waves to produce a detailed image of the inside of the body, and are already widely used to help diagnose other medical conditions.
The paper resulted from a large five year follow-up study and follows a series of papers from the original CE-MARC (Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease) study.
These papers have contributed to the growing body of evidence that cardiac MRI is the best option for the diagnosis and management of patients with coronary heart disease.
Earlier evidence from this BHF-funded study also showed that MRI is more cost-effective than SPECT in the diagnosis of coronary heart disease.
This research is expected to inform future clinical guidelines for the investigation of stable coronary heart disease. In doing so it could ease pressure on the NHS as only one hospital appointment is required for MRI, compared with two for SPECT.
Professor John Greenwood from the School of Medicine, who led the research, said: ‘Although SPECT is currently more widely available than MRI, the use of MRI across a wide spectrum of diseases means that it will be much more readily available for heart disease investigation in coming years.

University of Leeds http://tinyurl.com/z7cc2ny

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:16How to identify high risk heart disease patients
Page 171 of 240«‹169170171172173›»

Latest issue of International Hospital

April 2024

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

16 December 2025

HOPS 2026 Returns to Dubai — Setting a New Benchmark for Oncology Pharmacy in the Middle East

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription